Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: DYS015
MIFTS: 42

Dysentery

Categories: Gastrointestinal diseases
Genes Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Dysentery

About this section

MalaCards integrated aliases for Dysentery:

Name: Dysentery 12 44 15 73
Infectious Diarrhea 12 55 63

Classifications:

MalaCards categories:
Anatomical: Gastrointestinal diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:12384
ICD9CM 35 009.2
MeSH 44 D004403
SNOMED-CT 68 19213003
UMLS 73 C0013369
Sources

Summaries for Dysentery

About this section
PubMed Health : 63 About infectious diarrhea: Diarrhea is very common: In Germany, for instance, adults get it once a year on average, and it is even more common in children. It is usually caused by viruses, the most common of which are the highly contagious norovirus and rotavirus. Infectious diarrhea can also come from bacteria such as Salmonella or Campylobacter.In normal cases of diarrhea, you can usually just replace the fluids you lose and wait until the infection goes away. But more severe or longer lasting diarrhea needs to be treated because it can lead to the loss of dangerously high levels of fluid and salt, especially in young children and older people.

MalaCards based summary : Dysentery, also known as infectious diarrhea, is related to paratyphoid fever and abdominal tuberculosis, and has symptoms including diarrhea An important gene associated with Dysentery is TF (Transferrin). The drugs Omeprazole and Azithromycin have been mentioned in the context of this disorder. Affiliated tissues include colon, testes and liver.

Disease Ontology : 12 An intestinal infectious disease that involves inflammation of the intestines, especially colon, due to chemical irritants, bacteria, protozoa, or parasitic worms, which results in severe diarrhea with passage of mucus and blood.

Wikipedia : 76 Dysentery is an inflammatory disease of the intestine, especially of the colon, which always results in... more...

Sources

Related Diseases for Dysentery

About this section

Diseases related to Dysentery via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 154)
# Related Disease Score Top Affiliating Genes
1 paratyphoid fever 30.2 CRP IL1A
2 abdominal tuberculosis 30.1 ALB CRP
3 malaria 30.0 ALB CRP HP IL1A TF
4 appendicitis 29.9 ALB CRP ENO2
5 deficiency anemia 29.8 ALB CRP HP TF
6 protozoal dysentery 12.4
7 amebiasis 12.1
8 balantidiasis 11.7
9 shigellosis 11.7
10 campylobacteriosis 11.2
11 oesophagostomiasis 11.0
12 diarrhea 10.5
13 cholera 10.3
14 epstein-barr virus hepatitis 10.3 ALB TF
15 colitis 10.3
16 gastrointestinal tuberculosis 10.3 ALB CRP
17 yellow nail syndrome 10.3 ALB TF
18 paramyloidosis 10.3 ALB TTR
19 folic acid deficiency anemia 10.3 CRP TF
20 pyuria 10.3 ALB CRP
21 acquired angioedema 10.3 CRP HP
22 keratomalacia 10.3 TF TTR
23 median rhomboid glossitis 10.3 TF TTR
24 bronchus cancer 10.2 CRP ENO2
25 burns 10.2 CRP TTR
26 congenital disorder of glycosylation, type ia 10.2 HP TF
27 granulomatous hepatitis 10.2 CRP IFNA2
28 aleutian mink disease 10.2 ALB TTR
29 chronic graft versus host disease 10.2 ALB IL1A
30 rheumatic myocarditis 10.2 CRP IL1A
31 amyloidosis aa 10.2 CRP TTR
32 chronic ulcer of skin 10.2 ALB TTR
33 tuberculous peritonitis 10.2 ALB CRP
34 thyroid crisis 10.2 ALB TTR
35 hyperthyroxinemia 10.2 ALB TTR
36 chronic pulmonary heart disease 10.2 HP TTR
37 end stage renal failure 10.2 ALB CRP TF
38 uremia 10.2 ALB CRP TF
39 splenic abscess 10.2 CRP IER3IP1
40 urinary system disease 10.2 ALB CRP TF
41 pericardium disease 10.2 ALB CRP
42 iron overload in africa 10.2 HP TF
43 marasmus 10.2 ALB TF TTR
44 kwashiorkor 10.2 ALB TF TTR
45 gastroenteritis 10.2
46 pure red-cell aplasia 10.2 ALB TF
47 trypanosomiasis 10.2 ALB HP TF
48 bronchitis 10.2 ALB CRP TMPO
49 decubitus ulcer 10.2 ALB CRP TTR
50 cholangitis 10.2 ALB CRP HP

Comorbidity relations with Dysentery via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Dysentery:



Diseases related to Dysentery
Sources

Symptoms & Phenotypes for Dysentery

About this section

UMLS symptoms related to Dysentery:


diarrhea
Sources

Drugs & Therapeutics for Dysentery

About this section

PubMedHealth treatment related to Dysentery: 63

You lose fluids and electrolytes when you have diarrhea, so it is important to replace them. For acute, non-severe diarrhea you usually just need something like tea with sugar and some salted crackers. Foods that are gentle on the stomach is recommended too, such as rice, bananas or rusk bread. Some people also avoid coffee, fruit juices, sodas, alcohol and fatty foods to keep from irritating their bowel even more.Acute, non-severe diarrhea does not require special treatment in adults and teenagers. But it is a good idea for young children and older people, as well as people with more severe diarrhea, to replace fluids and electrolytes by using oral rehydration salts (electrolyte/glucose solutions) from the pharmacy. These are powders containing salts, minerals and glucose that can be dissolved in water. If these solutions are not available (for instance, while traveling) the following ingredients can be stirred into one liter of bottled or boiled water:Five tablespoons of sugarOne and a half level tablespoons of saltOne glass of packaged orange juiceIn addition to drinking fluids and using other treatments, foods or dietary supplements that have probiotic microorganisms (probiotics) in them can help to make the diarrhea go away faster.Depending on how severe the symptoms are and how long they last, other treatments may be considered too:Drugs like loperamide or racecadotril can help to slow down the activity of the bowel and lower the number of times you need to go to the bathroom. Loperamide is not suitable for children under the age of twelve years, and racecadotril is prescription-only for children.Sometimes certain types of yeast tablets (Perenterol) are also recommended. These tablets are thought to help the body get rid of the germs faster and to support natural gut flora. Charcoal tablets dissolved in water can also be taken to relieve diarrhea symptoms. But there is a lack of good-quality research in this area so no conclusions can be drawn about the benefits and harms of these treatment options.Antibiotics are only an option if the infection is bacterial. They can't fight viruses.

Drugs for Dysentery (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 161)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
2
Azithromycin Approved Phase 4,Phase 2,Phase 3,Not Applicable 83905-01-5 55185 447043
3
Loperamide Approved Phase 4,Phase 3,Not Applicable 53179-11-6 3955
4
Rifaximin Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 80621-81-4 6436173
5
Mebendazole Approved, Vet_approved Phase 4 31431-39-7 4030
6
Piperazine Approved, Vet_approved Phase 4 110-85-0 4837
7
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
8
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
9 Acidophilus Phase 4,Phase 3,Phase 1,Phase 2
10 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3,Early Phase 1
11 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Not Applicable
12 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Early Phase 1,Not Applicable
13 Antiparasitic Agents Phase 4,Phase 3,Phase 2
14 Antitubercular Agents Phase 4,Phase 3
15 Antacids Phase 4,Phase 1
16 Cola Phase 4,Not Applicable
17 Anti-Ulcer Agents Phase 4,Phase 1
18 Proton Pump Inhibitors Phase 4
19 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
20 Antidiarrheals Phase 4,Phase 3,Not Applicable
21 rifamycin SV Phase 4,Phase 2,Phase 3,Not Applicable
22 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3,Not Applicable
23 Rifamycins Phase 4,Phase 2,Phase 3,Not Applicable
24 Anthelmintics Phase 4
25 Citrate Phase 4
26 Antimitotic Agents Phase 4
27 Piperazine citrate Phase 4
28 Clavulanic Acids Phase 4
29 beta-Lactamase Inhibitors Phase 4
30 Amoxicillin-Potassium Clavulanate Combination Phase 4
31
Ciprofloxacin Approved, Investigational Phase 3,Phase 2 85721-33-1 2764
32
Iron Approved Phase 3,Phase 2,Not Applicable 7439-89-6 23925
33
Zinc Approved, Investigational Phase 3,Phase 2,Not Applicable 7440-66-6
34
Zinc sulfate Approved, Investigational Phase 3 7733-02-0
35
leucovorin Approved Phase 3,Not Applicable 58-05-9 6006 143
36
Nitazoxanide Approved, Investigational, Vet_approved Phase 3,Phase 2 55981-09-4 41684
37
Terlipressin Approved, Investigational Phase 3 14636-12-5 72081
38
Lactulose Approved Phase 2, Phase 3 4618-18-2 11333
39
Irinotecan Approved, Investigational Phase 3 100286-90-6, 97682-44-5 60838
40
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Not Applicable 59-30-3 6037
41
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3,Not Applicable 11103-57-4, 68-26-8 445354
42 Cytochrome P-450 Enzyme Inhibitors Phase 3,Phase 2,Not Applicable
43 Cytochrome P-450 CYP1A2 Inhibitors Phase 3,Phase 2,Not Applicable
44 Topoisomerase Inhibitors Phase 3,Phase 2,Not Applicable
45 Antirheumatic Agents Phase 3,Phase 2,Phase 1
46 Antibodies Phase 3
47 Immunoglobulins Phase 3
48 Vaccines Phase 3,Phase 2,Phase 1,Not Applicable
49 Immunologic Factors Phase 3,Phase 2,Phase 1
50 Trace Elements Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 109)
# Name Status NCT ID Phase Drugs
1 Improving Bowel Habits of Elderly With Probiotics and Non-probiotics Unknown status NCT02949882 Phase 4
2 New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management– Surveillance Study for Adverse Effects Completed NCT00490932 Phase 4 Hypo-osmolar ORS
3 Effects of Gastric Acid on Colonic Microbiome Completed NCT01901276 Phase 4 Omeprazole 40 mg bid
4 Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea Completed NCT00359970 Phase 4 Azithromycin 500 mg;Azithromycin 1000 mg;Loperamide
5 Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea Completed NCT00292344 Phase 4 Rifaximin and loperamide
6 Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population Completed NCT02385058 Phase 4 Mebendazole;Quinfamide;Placebo
7 Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial Completed NCT02871908 Phase 4 Lactobacillus reuteri DSM 17938;Placebo
8 Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children Recruiting NCT02765217 Phase 4 Lactobacillus reuteri DSM 17938;Placebo;Amoxicillin-Clavulanic Acid
9 Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea Terminated NCT01972932 Phase 4
10 Probiotics and the Prevention of Traveler's Diarrhea Terminated NCT01005849 Phase 4
11 Use of Bismuth Subsalicylate in Clostridium Difficile Colitis Withdrawn NCT03592082 Phase 4 Bismuth Subsalicylate;standard antibiotic therapy
12 Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea Withdrawn NCT00875875 Phase 4 Rifaximin
13 Randomized Controlled Field Trial of a Probiotics to Assess Its Role in Preventig Diarrhoea Unknown status NCT00534170 Phase 3
14 Efficacy of Rifaximin in Preventing Campylobacteriosis Completed NCT02280044 Phase 2, Phase 3
15 Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea Completed NCT01208922 Phase 3 Rifamycin SV MMX;Ciprofloxacin
16 Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel Completed NCT00368316 Phase 3
17 Impact of Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent Completed NCT00530374 Phase 3
18 Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal Completed NCT00109551 Phase 3 zinc sulphate dietary supplement;iron sulphate-folic acid dietary supplement
19 Fermented Milk and Fermented Rice on the Appearance of Respiratory and Gastrointestinal Symptoms Completed NCT01909128 Phase 3
20 Vitamin A Supplementation in Newborns Study Completed NCT00114868 Phase 3 Vitamin A
21 Zinc Supplementation in Shigella Patients Completed NCT00321126 Phase 3 Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks.
22 Study of Nitazoxanide in the Treatment of Amebiasis in Children Completed NCT00366730 Phase 3 Nitazoxanide
23 Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents Completed NCT00366236 Phase 3 Nitazoxanide
24 Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD) Completed NCT01142089 Phase 3 Placebo;Rifamycin SV MMX
25 Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study Completed NCT00993681 Phase 3
26 Rifaximin for Prevention of Travellers' Diarrhea Completed NCT00742469 Phase 3 Rifaximin;Placebo
27 Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults Completed NCT00737412 Phase 3
28 Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S. Completed NCT00328380 Phase 3 Rifaximin
29 Complementary Food Supplements for Reducing Childhood Undernutrition Completed NCT01562379 Phase 2, Phase 3
30 A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults Recruiting NCT03527173 Phase 2, Phase 3 GAHB-Placebo
31 Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial Recruiting NCT02473341 Phase 3 Bovine Colostrum;Placebo
32 Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy Recruiting NCT02464124 Phase 2, Phase 3 Nitazoxanide;Lactulose
33 Prevention of Irinotecan Induced Diarrhea by Probiotics Recruiting NCT02819960 Phase 3 PROBIO-FIX INUM®;Placebo
34 Protein Plus: Improving Infant Growth Through Diet and Enteric Health Recruiting NCT03683667 Phase 2, Phase 3 Azithromycin Oral Product;Placebos
35 A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea. Terminated NCT02920242 Phase 3 Rifaximin (Sandoz GmbH) tablet;Rifaximin (Xifaxan);Placebo
36 A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodifâ„¢ Tablets in Clostridium Difficile-associated Diarrhea Terminated NCT00466635 Phase 3 GT267-004 (tolevamer potassium sodium)
37 Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea Withdrawn NCT02736539 Phase 3 CBS 2004 (galacto-oligosaccharides);Placebo
38 A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans Unknown status NCT01243437 Phase 2 ciprofloxacin;doxyxcycline
39 Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea Completed NCT03447821 Phase 2 400 mg Rifamycin SV dosage;800 mg Rifamycin SV dosage;1200 mg Rifamycin SV dosage
40 Probiotics for Infectious Diarrhea in Children in South India Completed NCT01130792 Phase 1, Phase 2
41 Isoleucine Added ORS in Children With Diarrhoea Completed NCT01034228 Phase 2
42 Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate Completed NCT01080716 Phase 1, Phase 2
43 Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection Completed NCT00485134 Phase 1, Phase 2
44 Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity Completed NCT02354339 Phase 2
45 A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults Completed NCT02676895 Phase 2
46 Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a Completed NCT02646371 Phase 2
47 Therapeutic Induction of Endogenous Antibiotics Completed NCT00800930 Phase 2
48 Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine Completed NCT00210288 Phase 2
49 Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis. Completed NCT02265328 Phase 2
50 Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study Completed NCT01040325 Phase 2

Search NIH Clinical Center for Dysentery

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: dysentery

Sources

Genetic Tests for Dysentery

About this section
Sources

Anatomical Context for Dysentery

About this section

MalaCards organs/tissues related to Dysentery:

41
Colon, Testes, Liver, Bone, Kidney, Heart, Thyroid
Sources

Publications for Dysentery

About this section

Articles related to Dysentery:

(show top 50) (show all 1262)
# Title Authors Year
1
Chemical composition of Acacia farnesiana (L) wild fruits and its activity against Mycobacterium tuberculosis and dysentery bacteria. ( 30367988 )
2019
2
Effect of ambient temperature and its effect modifiers on bacillary dysentery in Jinan, China. ( 30373074 )
2019
3
Empirical antibiotic treatment for children suffering from dysentery, cholera, pneumonia, sepsis or severe acute malnutrition. ( 29790843 )
2018
4
The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low income settings. ( 29415075 )
2018
5
Occurrence of dysentery-like diarrhoea associated with<i>Brachyspira suanatina</i>infection in a German fattening pig farm. ( 29419486 )
2018
6
<i>Shigella</i> phages isolated during a dysentery outbreak reveal uncommon structures and broad species diversity. ( 29437962 )
2018
7
Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. ( 29790845 )
2018
8
Identification of a New Antimicrobial Resistance Gene Provides Fresh Insights Into Pleuromutilin Resistance in <i>Brachyspira hyodysenteriae</i>, Aetiological Agent of Swine Dysentery. ( 29971045 )
2018
9
Time Series Analysis of the Microbiota of Children Suffering From Acute Infectious Diarrhea and Their Recovery After Treatment. ( 29946306 )
2018
10
Residential proximity to high-density poultry operations associated with campylobacteriosis and infectious diarrhea. ( 29268955 )
2018
11
Gene Expression Levels of Peripheral Blood Mononuclear Cells IL-6 and TNF-&alpha; in Children with Bacterial and Viral Infectious Diarrhea. ( 30501830 )
2018
12
Use and Interpretation of Enteropathogen Multiplex Nucleic Acid Amplification Tests in Patients With Suspected Infectious Diarrhea. ( 30538605 )
2018
13
Long-Term Gastrointestinal Consequences are Frequent Following Sporadic Acute Infectious Diarrhea in a Tropical Country: A Prospective Cohort Study. ( 30171215 )
2018
14
Origanum majorana L extract exhibit positive cooperative effects on the main mechanisms involved in acute infectious diarrhea. ( 30217790 )
2018
15
Chinese clinical practice guidelines for acute infectious diarrhea in children. ( 30269306 )
2018
16
Diagnosis and Management of Infectious Diarrhea. ( 29889925 )
2018
17
The Role of Ion Transporters in the Pathophysiology of Infectious Diarrhea. ( 29928670 )
2018
18
Infectious diarrhea in autologous stem cell transplantation: high prevalence of coccidia in a South American center. ( 30057986 )
2018
19
Recent Prescription Patterns for Children with Acute Infectious Diarrhea. ( 30074577 )
2018
20
Serum procalcitonin levels can be used to differentiate between inflammatory and non-inflammatory diarrhea in acute infectious diarrhea. ( 30095641 )
2018
21
Infectious Diarrhea: IDSA Updates Guidelines for Diagnosis and Management. ( 29763277 )
2018
22
Association between floods and infectious diarrhea and their effect modifiers in Hunan province, China: A two-stage model. ( 29396332 )
2018
23
Challenges in developing mucosal vaccines and antibodies against infectious diarrhea in children. ( 29290097 )
2018
24
Assessing gut microbiota perturbations during the early phase of infectious diarrhea in Vietnamese children. ( 28767339 )
2018
25
Effect of antibiotics for infectious diarrhea on the duration of hospitalization: A retrospective cohort study at a single center in Japan from 2012 to 2015. ( 28986192 )
2018
26
Spatiotemporal Characteristics of Bacillary Dysentery from 2005 to 2017 in Zhejiang Province, China. ( 30149494 )
2018
27
An avirulent Brachyspira hyodysenteriae strain elicits intestinal IgA and slows down spread of swine dysentery. ( 28982389 )
2017
28
Antibiotic Therapy for Acute Watery Diarrhea and Dysentery. ( 28885920 )
2017
29
Spatial-temporal detection of risk factors for bacillary dysentery in Beijing, Tianjin and Hebei, China. ( 28946856 )
2017
30
Environmental Drivers and Predicted Risk of Bacillary Dysentery in Southwest China. ( 28708077 )
2017
31
The dysentery epidemic in Poland in 1920-1921 ( 28742314 )
2017
32
A novel multiplex qPCR targeting 23S rDNA for diagnosis of swine dysentery and porcine intestinal spirochaetosis. ( 28173799 )
2017
33
The Role of Probiotics in the Treatment of Dysentery: a Randomized Double-Blind Clinical Trial. ( 28321826 )
2017
34
Seasonal and geographical distribution of bacillary dysentery (shigellosis) and associated climate risk factors in Kon Tam Province in Vietnam from 1999 to 2013. ( 28637484 )
2017
35
Geraniol as a novel antivirulence agent against bacillary dysentery-causing Shigella sonnei. ( 29256316 )
2017
36
Impacts of ambient temperature on the burden of bacillary dysentery in urban and rural Hefei, China. ( 28294081 )
2017
37
A cohort study of the effect of winter dysentery on herd-level milk production. ( 28601443 )
2017
38
An optimized swine dysentery murine model to characterize shedding and clinical disease associated with &amp;quot;Brachyspira hampsonii&amp;quot; infection. ( 28830508 )
2017
39
Assessment on the burden of bacillary dysentery associated with floods during 2005-2009 in Zhengzhou City, China, using a time-series analysis. ( 29100875 )
2017
40
Antiprotozoal Constituents from Annona cherimola Miller, a Plant Used in Mexican Traditional Medicine for the Treatment of Diarrhea and Dysentery. ( 28216899 )
2017
41
Identification of weather variables sensitive to dysentery in disease-affected county of China. ( 27742060 )
2017
42
Spatiotemporal Risk of Bacillary Dysentery and Sensitivity to Meteorological Factors in Hunan Province, China. ( 29286297 )
2017
43
Impact of meteorological factors on the incidence of bacillary dysentery in Beijing, China: A time series analysis (1970-2012). ( 28796834 )
2017
44
Comparison of the Luminal and Mucosa-Associated Microbiota in the Colon of Pigs with and without Swine Dysentery. ( 28971100 )
2017
45
Treatment rates for injectable tiamulin and lincomycin as an estimate of morbidity in a swine herd with endemic swine dysentery. ( 28487591 )
2017
46
The Effects of Floods on the Incidence of Bacillary Dysentery in Baise (Guangxi Province, China) from 2004 to 2012. ( 28208681 )
2017
47
Projected burden of disease for bacillary dysentery due to flood events in Guangxi, China. ( 28605848 )
2017
48
Evaluation of a multiplex panel for the diagnosis of acute infectious diarrhea in immunocompromised hematologic patients. ( 29099868 )
2017
49
2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. ( 29194529 )
2017
50
The evaluation of critically ill transplant patients with infectious diarrhea. ( 28759468 )
2017
Sources

Variations for Dysentery

About this section
Sources

Expression for Dysentery

About this section
Search GEO for disease gene expression data for Dysentery.
Sources

Pathways for Dysentery

About this section
Sources

GO Terms for Dysentery

About this section

Cellular components related to Dysentery according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.61 ALB CRP HP IFNA2 IL1A LTF
2 blood microparticle GO:0072562 9.33 ALB HP TF
3 extracellular space GO:0005615 9.28 ALB CRP ENO2 HP IFNA2 IL1A

Biological processes related to Dysentery according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.26 ALB LTF TF TTR
2 retina homeostasis GO:0001895 8.8 ALB LTF TF

Molecular functions related to Dysentery according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 antioxidant activity GO:0016209 8.62 ALB HP
Sources

Sources for Dysentery

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....